Tumor News and Research

RSS

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah (tisagenlecleucel, formerly CTL019) led to long-lasting remissions in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL).

3 Dec 2018

Researchers reveal how some cancers trick healthy cells into protecting tumors

Many factors affect cancer treatment outcome, such as the size and location of the tumor, availability of effective treatments, and timing of intervention. But some cancers are so aggressive that outcome is poor, even after early diagnosis and chemotherapy.

30 Nov 2018

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

30 Nov 2018

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Glioblastoma, a deadly brain cancer that has grabbed headlines for claiming the lives of Sens. Edward Kennedy and John McCain, could be "tricked" into sparing more of its victims.

30 Nov 2018

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

Medical physicist Dr. Aswin Hoffmann and his team from the Institute of Radiooncology - OncoRay at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) are the first researchers worldwide to combine magnetic resonance imaging (MRI) with a proton beam, thus demonstrating that in principle, this commonly used imaging method can indeed work with particle beam cancer treatments.

29 Nov 2018

Insights from the Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the 2018 Shunde Biomedical Industry Investment Promotion Conference was successfully held at the Ramada Plaza Hotel, Shunde, GuangDong, China

From Aurora Biomed Inc. 29 Nov 2018

Researchers find how skin cancer cells avoid attack by the immune system

Researchers at the Mainz University Medical Center discovered a new signal pathway employed by skin cancer cells to avoid attack by the immune system. In an animal model and through analysis of human tissue samples, Dr. Toszka Bohn, Dr. Steffen Rapp and Professor Tobias Bopp were able to demonstrate the significant role played by a specific protein called ICER.

29 Nov 2018

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

The New York Genome Center has received approval from the New York State Department of Health to offer whole genome and RNA transcriptome sequencing in its Clinical Laboratory Evaluation Program-certified laboratory.

29 Nov 2018

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration from minutes to under a second.

29 Nov 2018

Revolutionary new technology sheds light on why cancers form in specific cell types

While many cells in our bodies can accumulate oncogenic mutations, the majority of these events do not lead to tumor formation as these abnormal cells are eliminated by defense mechanisms.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them, suggests a study published today in the journal Cancer Research.

29 Nov 2018

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Veterans Health Administration hospitals offer something Medicare does not: In some cases, treatments meant to alter the course of a disease can be offered along with hospice care.

28 Nov 2018

Cryoablation shows potential as a treatment for low-risk breast cancer

Researchers at CentraState Medical Center have shown that cryoablation, also known as cryotherapy, could be an effective treatment for low-risk breast cancer.

28 Nov 2018

UNLV researchers suggest new way to classify negative symptoms of schizophrenia

The onset of schizophrenia in young adults can put an immediate halt to life goals, with one set of symptoms being particularly debilitating.

28 Nov 2018

UT Southwestern researchers discover enzyme that promotes tumor growth

UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.

28 Nov 2018

Scientists visualize action of immune cells in response to cancer cell proliferation

As tumors develop, they evolve genetically. How does the immune system act when faced with tumor cells? How does it exert pressure on the genetic diversity of cancer cells? Scientists from the Institut Pasteur and Inserm used in vivo video techniques and cell-specific staining to visualize the action of immune cells in response to the proliferation of cancer cells.

28 Nov 2018

Tumor News and Research

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

Researchers reveal how some cancers trick healthy cells into protecting tumors

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

Insights from the Shunde Biomedical Industry Investment Promotion Conference

Researchers find how skin cancer cells avoid attack by the immune system

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

Revolutionary new technology sheds light on why cancers form in specific cell types

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Cryoablation shows potential as a treatment for low-risk breast cancer

UNLV researchers suggest new way to classify negative symptoms of schizophrenia

UT Southwestern researchers discover enzyme that promotes tumor growth

Scientists visualize action of immune cells in response to cancer cell proliferation

New therapeutic drug monitoring service could benefit children with cancer

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Using Pre-Clinical Imaging to Detect Cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News